It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the pelvis while preserving the lower limbs and surrounding tissues.
Team OO
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the pelvis while preserving the lower limbs and surrounding tissues.
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the upper leg bone (femur) and in most instances replacing the bone and hip joint with a special customizable proximal femur tumor prosthesis.
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the thigh bone (femur) and in most instances replacing the entire bone with a special customizable total femur tumor prosthesis.
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the arm bone (humerus) and in most instances replacing the bone/elbow with a special customizable distal humerus tumor prosthesis.
by Team OO | Oct 15, 2025 | Surgeries
A proximal humerus prosthetic replacement is a procedure that involves removing a tumor, usually malignant or benign aggressive, of the upper arm bone/humerus and in most instances replacing the bone and shoulder with a special customizable proximal humerus tumor prosthesis.
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (malignant or benign) of the bone while preserving the surrounding healthy bone and soft tissues and reconstructing the defect (space where tumor was removed) with a tumor prosthesis.
by Team OO | Oct 15, 2025 | Surgeries
It is a procedure that involves removing a tumor (usually malignant or benign aggressive) of the bone and replacing it with a metal prosthesis to preserve the limb.
by Team OO | Oct 6, 2025 | Uncategorized
Conventional chondrosarcoma is a rare primary bone cancer and the second most common bone sarcoma. Dr. James C. Wittig explains its presentation, radiology, pathology, treatment, prognosis, and the latest clinical research findings.
by Team OO | Sep 25, 2025 | Uncategorized
Dr. James C. Wittig, founder of the Mount Sinai Musculoskeletal Pathology Course, participated as a 2025 presenter. His lecture on malignant cartilage tumors and case discussions advanced global knowledge in orthopedic oncology, underscoring his dual role as surgeon and educator.
by Team OO | Sep 8, 2025 | Uncategorized
Three years after undergoing limb sparing surgery for Ewing sarcoma, a rare bone cancer, Dr. James C. Wittig’s infant patient is thriving. The case highlights how advanced orthopedic oncology can preserve function, growth, and quality of life.